文献速递腹部MR

ADC 鉴别肝细胞腺瘤与肝癌及转移瘤的系统综述与 Meta 分析

Role of ADC in differentiating hepatocellular adenoma vs. hepatocellular carcinoma and metastatic liver lesions: systematic review and meta-analysis.
PubMed 文献 · Abdom Radiol (NY) · 2026-01-03

HCA 平均 ADC 值(1.34×10⁻³ mm²/s)略高于 HCC(1.23×10⁻³ mm²/s),差异有统计学意义但与转移灶(1.25×10⁻³ mm²/s)无显著差异。ADC 目前仅具有限的补充诊断价值,不能替代活检。

要点

  • HCA 较 HCC 的 ADC 均值仅高 0.12×10⁻³ mm²/s,效应量小,单独用于鉴别价值有限
  • HCA 与转移灶 ADC 值存在较大重叠,不能仅凭 ADC 排除转移
  • 可疑 HCA 时仍应优先考虑活检等确诊手段,ADC 只作补充参考

核心结论

  • HCA 的 ADC 值仅略高于 HCC,且与转移灶有较大重叠,ADC 目前仅具有限的补充诊断作用,不能可靠替代活检

研究设计与样本

  • 系统检索 PubMed、Embase、Web of Science、Cochrane Library 截至 2025 年 8 月 10 日
  • 纳入标准为经组织学或影像学确诊的 HCA 和恶性局灶性肝病变,并报告定量 ADC 值
  • 两名评价者独立提取数据并使用 QUADAS-2 评估偏倚风险,采用随机效应模型进行 Meta 分析

关键影像表现/征象

  • HCA 平均 ADC 值为 1.34×10⁻³ mm²/s,HCC 为 1.23×10⁻³ mm²/s,转移灶为 1.25×10⁻³ mm²/s
  • HCA 与 HCC 的 ADC 值存在较多重叠,差异幅度仅为 0.12×10⁻³ mm²/s
  • 转移灶的 ADC 值与 HCA 重叠明显,反映转移性病变生物学特征的异质性

诊断标准与关键数值

  • HCA 与 HCC 比较:平均差 0.12×10⁻³ mm²/s,p=0.042,标准化均数差 SMD=0.35
  • HCA 与转移灶比较:平均差 0.17×10⁻³ mm²/s,p=0.153,标准化均数差 SMD=0.54
  • 所有比较的发表偏倚评估均为阴性

临床应用与阅片要点

  • 在可疑 HCA 的鉴别诊断中,ADC 值可作为辅助参数,但不应作为决定性依据
  • 阅片时需注意 HCA、HCC、转移灶三者 ADC 值区间重叠较大,避免过度解读轻度差异
  • 对于 ADC 值较高的肝内病灶,不能据此排除恶性可能,尤其需警惕转移瘤的异质性
  • 报告 ADC 值时宜结合常规序列形态学特征,避免单独引用阈值进行定性诊断

局限性

  • HCA 与转移灶的比较无显著差异,原因为转移性病变生物学异质性较大
  • 效应量较小且存在明显未解释的异质性
  • 部分纳入研究声称 ADC 有鉴别价值,但本 Meta 分析综合后不支持该结论

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Differentiating hepatocellular adenoma (HCA) from malignant focal liver lesions (FLLs), including hepatocellular carcinoma (HCC), and metastases, is challenging yet clinically important. Given biopsy-associated bleeding risks in suspected HCA and differing treatment strategies, accurate noninvasive imaging biomarkers are needed.

METHODS: A systematic literature search of PubMed, Embase, Web of Science, and Cochrane Library up to August 10, 2025, identified studies reporting quantitative apparent diffusion coefficient (ADC) values for histologically or imaging-confirmed HCA and malignant FLLs. Data extraction and risk-of-bias assessment were performed independently by two reviewers using QUADAS-2. Random-effects meta-analysis calculated pooled mean ADC values, mean differences, standardized mean differences (SMDs), and percentage differences.

RESULTS: Sixteen studies comprising 1279 lesions (212 HCA, 697 HCC, 370 metastases) were included. Mean ADC values were 1.34 × 10⁻³ mm²/s for HCA, 1.23 × 10⁻³ mm²/s for HCC, and 1.25 × 10⁻³ mm²/s for metastases. HCA demonstrated modest yet significantly higher ADC than HCC (mean difference = 0.12 × 10⁻³ mm²/s, p = 0.042; SMD = 0.35). No significant difference was observed between HCA and metastases (mean difference = 0.17 × 10⁻³ mm²/s, p = 0.153; SMD = 0.54), likely reflecting heterogeneity in metastatic biology. Publication bias assessment was negative for all comparisons.

CONCLUSION: ADC values were slightly higher in HCA than HCC but largely overlapped with metastases; given the small effect sizes and substantial unexplained heterogeneity, despite the claims by several included studies, ADC currently has only a limited, complementary role in lesion characterization and cannot reliably replace biopsy.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zare, Mohebbi, Hodoodi, et al. Role of ADC in differentiating hepatocellular adenoma vs. hepatocellular carcinoma and metastatic liver lesions: systematic review and meta-analysis. Abdom Radiol (NY). 2026. PMID: 41483152. doi:10.1007/s00261-025-05357-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。